Innovative and mundane

Takeda supports IAEA covid-19 project with €4.35 M

Biopharmaceutical leader Takeda Pharmaceutical Company Limited has committed to donating 500 million yen (around €4.35 million) in support of a global initiative launched by the International Atomic Energy Agency (IAEA) to help countries combat the COVID-19 pandemic.